RNU6-1014P

Across TCGA pan-cancer cohorts, RNU6-1014P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-1014P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1014P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1014P expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

KIRC, READ, and SKCM are the cancer types where RNU6-1014P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.180	0.796	.001	90	view →
READ	OS	Tertile	II,III,IV	0.198	0.816	<.001	90	view →
SKCM	DFS	Tertile	All	0.037	0.738	<.001	54	view →
BLCA	OS	Tertile	All	0.214	0.618	.027	36	view →
CESC	OS	Tertile	All	0.095	0.585	.038	18	view →
LIHC	OS	Tertile	All	0.166	0.688	.033	18	view →
GBM	OS	Tertile	All	0.530	0.383	.043	3	view →
LGG	OS	Tertile	All	0.775	0.854	.035	1	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-1014P–KIRC (DFS)

Open the KIRC breakdown →